Corporate Governance

Celebrities are paid huge amounts by companies for endorsing products that at times turn out to be harmful for the consumers. Examine the ethical dimensions involved in such instances.

10 marks · 150 words · Answered by 9 toppers · CSE 2016–2019

Corporate GovernanceDimensions of Ethics

While discussing the ethical issues that journalists face on a regular basis, examine the causes of increased sensationalism in news media in recent times.

10 marks · 150 words · Answered by 9 toppers · CSE 2016–2019

Corporate GovernanceDimensions of Ethics

Competition, it is argued, spurs the best of performance, however, can it also instigate cheating and unethical behaviour? Discuss with adequate examples.

10 marks · 150 words · Answered by 4 toppers · CSE 2016–2019

Dimensions of EthicsEthical Dilemmas in Government

Dr. A.K. Singh, a professor of medicine, is a prominent cardiologist. His personal financial investments include significant stock holdings in three publicly traded biotechnology firms. He is approached by one of these firms to be a lead investigator in a therapeutic trial of a novel agent for preventing tissue damage from myocardial infarction (MI). This will be a randomized double-blinded, placebo-controlled clinical trial (neither patient nor physician will know whether the drug under investigation or a placebo is being used in a given patient). Dr. Singh is quite familiar with the preliminary animal and cell biology work in the area and believes that there is an excellent chance that this new drug will result in a significant improvement in survival and reduce damage to the heart muscle. He even thinks this novel agent may reduce the risk of heart failure and irregular beats. Dr. Singh's group is one of the few cardiology groups fully prepared to carry out this investigation, which is why he was contacted. He cares for a large number of patients with MI and believes that he could enroll numerous patients efficiently. The drug will only be available to his patients if his group participates in the trial. The company is offering Rs. 25 lakh for each patient enrolled. As a lead investigator, he will become much better known and will likely experience an increase in referrals if the trial succeeds. 1. Is Dr. Singh's participation in this study appropriate? Justify your position. 2. Does Dr. Singh have a conflict of interest? If so, what is the nature of the conflict? How could it be mitigated. 3. How would the nature of the conflict of interest be different had he not already owned stock, but instead had been offered stock as a form of compensation for conducting the study?

20 marks · 250 words · Answered by 3 toppers · CSE 2016–2018

Conflict of InterestCorporate Governance

Dr. A.K. Singh, a professor of medicine, is a prominent cardiologist. His personal financial investments include significant stock holdings in three publicly traded biotechnology firms. He is approached by one of these firms to be a lead investigator in a therapeutic trial of a novel agent for preventing tissue damage from myocardial infarction (MI). This will be a randomized double-blinded, placebo-controlled clinical trial (neither patient nor physician will know whether the drug under investigation or a placebo is being used in a given patient). Dr. Singh is quite familiar with the preliminary animal and cell biology work in the area and believes that there is an excellent chance that this new drug will result in a significant improvement in survival and reduce damage to the heart muscle. He even thinks this new agent may reduce the risk of heart failure and irregular beats. Dr. Singh's group is one of the few cardiology groups fully prepared to carry out this investigation, which is why he was contacted. He cares for a large number of patients with MI and believes that he could enroll numerous patients efficiently. The drug will only be available to his patients if his group participates in the trial. The company is offering Rs. 25 lakh for each patient enrolled. As a lead investigator, he will become much better known and will likely experience an increase in referrals if the trial succeeds. 1. Is Dr. Singh's participation in this study appropriate? Justify your position. 2. Does Dr. Singh have a conflict of interest? If so, what is the nature of the conflict? How could it be mitigated. 3. How would the nature of the conflict of interest be different had he not already owned stock, but instead had been offered stock as a form of compensation for conducting the study?

20 marks · 250 words · Answered by 1 topper · CSE 2016

Conflict of InterestCorporate Governance

Since politics and business are inseparable, a good governance eco-system is a precondition for corporate governance. Comment.

10 marks · 150 words · Answered by 1 topper · CSE 2016

Corporate GovernanceAccountability and Ethical Governance